WrapManager Inc’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,192
Closed -$317K 214
2025
Q1
$317K Sell
5,192
-1,011
-16% -$58.9K 0.08% 151
2024
Q4
$351K Buy
6,203
+1,170
+23% +$65.4K 0.09% 142
2024
Q3
$260K Sell
5,033
-2,059
-29% -$96.6K 0.07% 187
2024
Q2
$295K Sell
7,092
-2,811
-28% -$126K 0.08% 192
2024
Q1
$537K Buy
+9,903
New +$504K 0.15% 121
2023
Q3
Sell
-7,117
Closed -$455K 277
2023
Q2
$455K Buy
7,117
+10
+0.1% +$671 0.14% 154
2023
Q1
$493K Sell
7,107
-391
-5% -$27.6K 0.15% 151
2022
Q4
$539K Sell
7,498
-2,418
-24% -$182K 0.17% 125
2022
Q3
$705K Buy
9,916
+865
+10% +$62.7K 0.24% 100
2022
Q2
$697K Sell
9,051
-4,083
-31% -$311K 0.22% 102
2022
Q1
$959K Buy
13,134
+5,438
+71% +$365K 0.26% 95
2021
Q4
$480K Buy
7,696
+2,936
+62% +$172K 0.12% 168
2021
Q3
$282K Buy
4,760
+535
+13% +$35.2K 0.07% 256
2021
Q2
$282K Buy
4,225
+143
+4% +$9.32K 0.07% 265
2021
Q1
$258K Sell
4,082
-2,498
-38% -$155K 0.07% 241
2020
Q4
$408K Sell
6,580
-622
-9% -$38.2K 0.12% 164
2020
Q3
$434K Buy
7,202
+1,695
+31% +$102K 0.15% 154
2020
Q2
$324K Buy
+5,507
New +$329K 0.12% 170

Other funds holding BMY

WrapManager Inc's BMY Position: Q2 2025 in Review

WrapManager Inc sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 5,192 shares — an estimated $317K sold.

WrapManager Inc first reported a position in BMY in Q2 2020 and held it in 18 quarters. The position peaked at $959K in Q1 2022. 2,292 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

  • WrapManager Inc reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
  • WrapManager Inc sold 5,192 Bristol-Myers Squibb shares in Q2 2025, an estimated $317K.
  • WrapManager Inc first reported a position in Bristol-Myers Squibb in Q2 2020 and held it in 18 quarters.
  • WrapManager Inc's Bristol-Myers Squibb position peaked at $959K in Q1 2022.
  • 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on WrapManager Inc's 13F filing for Q2 2025, filed 8 Aug 2025.